To amend the Harmonized Tariff Schedule for the United States to establish a new subheading in chapter 39 for silicone prosthetics for women who are breast cancer survivors and a new subheading in chapter 90 for mastectomy bras.
Latest action (24 Aug 2026): Introduced
What this bill does
H.R. 10147 would amend the Harmonized Tariff Schedule of the United States to create two new tariff subheadings: one in chapter 39 for silicone prosthetic breast forms used with mastectomy bras, and one in chapter 90 for mastectomy brassieres themselves. Under the bill, both categories of goods would be assigned a general duty rate of 0%, effectively eliminating import tariffs on these specific items when they enter the United States for consumption. The change would take effect for goods entering the country on or after January 1, 2027.
The bill would primarily affect breast cancer survivors who use silicone breast prostheses and mastectomy bras, as well as the manufacturers, importers, and retailers of these medical products. By removing tariffs on these items, the bill could lower import costs associated with these goods, though the text itself does not specify effects on consumer prices.
The bill was introduced in the House on August 24, 2026, by Rep. Carol Miller of West Virginia, with Rep. Terri Sewell as a cosponsor, and has been referred to the House Committee on Ways and Means, which has jurisdiction over tariff and trade matters. As an introduced bill, it must be considered and approved by that committee, then pass the full House, and subsequently be approved by the Senate and signed by the President before it could become law. No further action beyond introduction has occurred.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
This bill is in the first stage of the legislative process. It was introduced into Congress on August 24, 2026. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.
Common questions
- What does H.R. 10147 do?
- H.R. 10147 would amend the Harmonized Tariff Schedule of the United States to create two new tariff subheadings: one in chapter 39 for silicone prosthetic breast forms used with mastectomy bras, and one in chapter 90 for mastectomy brassieres themselves. Under the bill, both categories of goods would be assigned a general duty rate of 0%, effectively eliminating import tariffs on these specific items when they enter the United States for consumption. The change would take effect for goods entering the country on or after January 1, 2027. The bill would primarily affect breast cancer survivors who use silicone breast prostheses and mastectomy bras, as well as the manufacturers, importers, and retailers of these medical products. By removing tariffs on these items, the bill could lower import costs associated with these goods, though the text itself does not specify effects on consumer prices. The bill was introduced in the House on August 24, 2026, by Rep. Carol Miller of West Virginia, with Rep. Terri Sewell as a cosponsor, and has been referred to the House Committee on Ways and Means, which has jurisdiction over tariff and trade matters. As an introduced bill, it must be considered and approved by that committee, then pass the full House, and subsequently be approved by the Senate and signed by the President before it could become law. No further action beyond introduction has occurred.
- Has H.R. 10147 become law?
- Not yet. As of 24 Aug 2026, H.R. 10147 is introduced.
- Who sponsored H.R. 10147?
- H.R. 10147 was sponsored by Rep. Carol Miller [R-WV1] (Republican-WV), with 1 cosponsor.
- What's the latest action on H.R. 10147?
- Introduced (24 Aug 2026).
Related bills in Foreign Trade and International Finance
BEEF Act
Housing Tariff Exclusion Act
Stop China’s Exploitation of Congolese Children and Adult Forced Labor through Cobalt Mining Act
BAD DEAL Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.